| Literature DB >> 35778422 |
Minji Kim1, Tatsunori Masaki2, Kentaro Ikuta2, Eiji Iwamoto2, Koki Nishihara1, Makoto Hirai1,3, Yoshinobu Uemoto1, Fuminori Terada1,4, Sanggun Roh5.
Abstract
In this study, using enteric methane emissions, we investigated the metabolic characteristics of Japanese Black cattle. Their methane emissions were measured at early (age 13 months), middle (20 months), and late fattening phases (28 months). Cattle with the highest and lowest methane emissions were selected based on the residual methane emission values, and their liver transcriptome, blood metabolites, hormones, and rumen fermentation characteristics were analyzed. Blood β-hydroxybutyric acid and insulin levels were high, whereas blood amino acid levels were low in cattle with high methane emissions. Further, propionate and butyrate levels differed depending on the enteric methane emissions. Hepatic genes, such as SERPINI2, SLC7A5, ATP6, and RRAD, which were related to amino acid transport and glucose metabolism, were upregulated or downregulated during the late fattening phase. The above mentioned metabolites and liver transcriptomes could be used to evaluate enteric methanogenesis in Japanese Black cattle.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35778422 PMCID: PMC9249741 DOI: 10.1038/s41598-022-15146-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Comparisons of methane emissions and blood metabolite levels in HME vs LME cattle during the fattening period. T1: early fattening phases (13 months of age), T2: middle fattening phases (20 months of age), T3: late fattening phases (28 months of age). HME: group of high methane emission cattle (n = 6), LME: group of low methane emission cattle (n = 6). BUN: blood urea nitrogen, NEFA: non-esterified fatty acid, ALP: alkaline phosphatase, AST: aspartate aminotransferase, ALT: alanine aminotransferase, γ-GTP: gamma(γ)-glutamyl transferase, BHBA: β-hydroxybutyric acid, IGF-I: insulin-like growth factor 1. Data are presented as mean ± SEM. *p < 0.1, **p < 0.05, and ***p < 0.01.
Figure 2Comparisons of blood amino acid levels in HME vs LME cattle during the fattening period. T1: early fattening phases (13 months of age), T2: middle fattening phases (20 months of age), T3: late fattening phases (28 months of age). HME: group of high methane emission cattle (n = 6), LME: group of low methane emission cattle (n = 6). Data are presented as mean ± SEM. *p < 0.1, **p < 0.05, and ***p < 0.01.
Figure 3Compositions of rumen fermentations in HME vs LME cattle during the fattening period. T1: early fattening phases (13 months of age), T2: middle fattening phases (20 months of age), T3: late fattening phases (28 months of age). HME: group of high methane emission cattle (n = 6), LME: group of low methane emission cattle (n = 6). VFA: volatile fatty acid. Data are presented as mean ± SEM. *p < 0.1, **p < 0.05, and ***p < 0.01.
Mean growth performance and feed intake in Japanese black cattle during the fattening period.
| Variable | T1 | T2 | T3 | |||
|---|---|---|---|---|---|---|
| HME | LME | HME | LME | HME | LME | |
| Average body weight (kg) | 398.33 (385.50–407.50) | 387.50 (372.00–405.00) | 590.83 (567.00–643.57) | 562.50 (525.86–600.57) | 730.48 (675.71–788.86) | 724.48 (676.86–777.14) |
| Average daily gain (kg/day) | 0.78 (0.45–1.07) | 0.89 (0.84–0.93) | 0.88 (0.70–1.04) | 0.83 (0.69–0.94) | 0.61 (0.52–0.71) | 0.66 (0.59–0.80) |
| Concentrate | 5.23 (5.06–5.33) | 5.32 (5.30–5.33) | 7.07 (6.02–8.29) | 7.19 (6.24–8.51) | 6.44 (6.02–7.55) | 6.64 (5.24–7.83) |
| Rice straw | 1.27 (0.85–1.70) | 1.39 (0.85–1.70) | 0.70 (0.51–0.95) | 0.80 (0.51–1.02) | 0.61 (0.43–0.79) | 0.68 (0.43–0.79) |
| Kraft pulp feed | 0.44 (0.00–0.85) | 0.29 (0.00–0.85) | 0.23 (0.00–0.51) | 0.15 (0.00–0.46) | 0.22 (0.00–0.44) | 0.14 (0.00–0.37) |
| Dry matter | 6.94 (6.76–7.04) | 7.01 (6.94–7.04) | 8.01 (6.86–9.04) | 8.14 (7.09–9.52) | 7.26 (6.67–8.21) | 7.45 (6.03–8.12) |
| Total digestible nutrients | 5.23 (4.99–5.50) | 5.23 (5.06–5.48) | 6.40 (5.55–7.22) | 6.47 (5.56–7.52) | 5.84 (5.32–6.59) | 5.97 (5.52–7.05) |
| Crude protein | 0.89 (0.87–0.93) | 0.91 (0.89–0.93) | 1.05 (0.87–1.23) | 1.07 (0.94–1.27) | 0.80 (0.72–0.94) | 0.83 (0.65 -0.97) |
T1: early fattening phase (13 months of age), T2: middle fattening phases (20 months of age), T3: late fattening phases (28 months of age). HME: group of high methane emission cattle (n = 6), LME: group of low methane emission cattle (n = 6); The cattle were fed concentrates as follows: T1: steam-flaked corn 42%, wheat bran 27%, corn gluten meal 10%, soybean meal 12%, soybean hull 6%, salt 1% (TDN 71.2%, CP 15.9%); T2: steam-flacked corn 42%, barley 14%, wheat bran 21%, corn gluten meal 5%, soybean meal 10%, soybean hull 6%, salt 1% (TDN 72.5%, CP 14.4%); T3: steam-flacked corn 44%, barley 25%, wheat bran 14%, soybean meal 5%, soybean hull 10%, salt 1% (TDN 72.8%, CP 12.0%). The rice straw intakes were as follows: DM 87.8%, TDN 37.7%, CP 4.7%. The kraft pulp feed intakes were as follows: DM 76.9%, TDN 51.1%, CP 0.3%.
Mean carcass traits in HME vs LME.
| Variable | HME | LME | SEM | |
|---|---|---|---|---|
| Live weight (kg) | 779.67 | 760.00 | 10.17 | 0.31 |
| Growth rate (kg/day) | 0.84 | 0.82 | 0.01 | 0.49 |
| Carcass weight (kg) | 478.33 | 468.17 | 7.84 | 0.49 |
| Eye muscle area (cm2) | 59.33 | 56.33 | 1.83 | 0.39 |
| Rib thickness (cm) | 8.15 | 7.75 | 0.19 | 0.31 |
| Subcutaneous fat (cm) | 3.02 | 2.80 | 0.21 | 0.59 |
| BMS | 8.33 | 8.33 | 0.43 | 0.94 |
HME: group of high methane emission cattle (n = 6), LME: group of low methane emission cattle (n = 6). Values indicate mean. SEM: standard error of the mean, BMS: beef marbling score (Japanese standards ranged from 1, which contains no visible marbling, up to 12, which is heavily marbled).
Figure 4Heat map illustrating the hierarchical cluster of differentially expressed genes in HME vs LME in late fattening phases. HME: group of high methane emission cattle (n = 5), LME: group of low methane emission cattle (n = 5).
Top 10 differentially expressed genes in HME vs LME in late fattening phases.
| Gene name | Description | log2FoldChange | |
|---|---|---|---|
| Serpin family I member 2 | < 0.01 | 5.01 | |
| Myosin VIIB | < 0.01 | 4.61 | |
| Solute carrier family 7 member 5 | < 0.01 | − 2.63 | |
| Hemicentin 1 | < 0.01 | 2.12 | |
| Keratinocyte associated protein 3 | < 0.01 | − 2.08 | |
| Prune homolog 2 with BCH domain | < 0.01 | − 1.81 | |
| Microtubule associated protein 1B | < 0.01 | 1.69 | |
| Slit guidance ligand 3 | < 0.01 | 1.57 | |
| Mitochondrially encoded ATP synthase membrane subunit 6 | < 0.01 | − 1.54 | |
| Ras related glycolysis Inhibitor and calcium channel regulator | < 0.01 | 1.53 |
DEGs: differentially expressed genes.
Gene ontology of differentially expressed genes in HME vs LME in late fattening phases.
| Ontology | GO Term ID | Description | No. of DEGs | P-value |
|---|---|---|---|---|
| Biological processes | GO:0016192 | vesicle-mediated transport | 6 | 0.01 |
| GO:0051640 | Organelle localization | 4 | 0.02 | |
| GO:0045321 | Leukocyte activation | 4 | 0.06 | |
| GO:0001775 | Cell activation | 4 | 0.08 | |
| GO:0006909 | Phagocytosis | 3 | 0.01 | |
| GO:0050770 | Regulation of axonogenesis | 3 | 0.02 | |
| GO:0002366 | Leukocyte activation involved in immune response | 3 | 0.04 | |
| GO:0002263 | Cell activation involved in immune response | 3 | 0.04 | |
| GO:0010769 | Regulation of cell morphogenesis involved in differentiation | 3 | 0.06 | |
| GO:0010975 | Regulation of neuron projection development | 3 | 0.07 | |
| GO:0051656 | Establishment of organelle localization | 3 | 0.07 | |
| GO:0007409 | Axonogenesis | 3 | 0.09 | |
| GO:0061564 | Axon development | 3 | 0.10 | |
| GO:0006805 | Xenobiotic metabolic process | 2 | 0.03 | |
| GO:0071466 | Cellular response to xenobiotic stimulus | 2 | 0.04 | |
| GO:0043303 | Mast cell degranulation | 2 | 0.04 | |
| GO:0009620 | Response to fungus | 2 | 0.04 | |
| GO:0002448 | Mast cell mediated immunity | 2 | 0.04 | |
| GO:0009410 | Response to xenobiotic stimulus | 2 | 0.04 | |
| GO:0002279 | Mast cell activation involved in immune response | 2 | 0.05 | |
| GO:0032418 | Lysosome localization | 2 | 0.06 | |
| GO:0045576 | Mast cell activation | 2 | 0.06 | |
| GO:0043299 | Leukocyte degranulation | 2 | 0.07 | |
| GO:0002275 | Myeloid cell activation involved in immune response | 2 | 0.08 | |
| GO:0002444 | Myeloid leukocyte mediated immunity | 2 | 0.09 | |
| Cellular composition | GO:0005576 | Extracellular region | 10 | 0.04 |
| GO:0044421 | Extracellular region part | 9 | 0.05 | |
| GO:0070062 | Extracellular exosome | 7 | 0.09 | |
| GO:1903561 | Extracellular vesicle | 7 | 0.09 | |
| GO:0043230 | Extracellular organelle | 7 | 0.09 | |
| GO:0031012 | Extracellular matrix | 3 | 0.10 | |
| GO:0005903 | Brush border | 2 | 0.10 | |
| Molecular functions | GO:0005509 | Calcium ion binding | 4 | 0.05 |
| GO:1901681 | Sulfur compound binding | 3 | 0.02 |
GO: gene ontology, DEGs: differentially expressed genes.
Gene ontology of differentially expressed genes related to immune activity in HME vs LME in late fattening phases.
| GO Term ID | Description | No. of DEGs | DEGs | |
|---|---|---|---|---|
| GO:0002366 | Leukocyte activation involved in immune response | 3 | 0.04 | |
| GO:0002263 | Cell activation involved in immune response | 3 | 0.04 | |
| GO:0006805 | Xenobiotic metabolic process | 2 | 0.03 | |
| GO:0071466 | Cellular response to xenobiotic stimulus | 2 | 0.04 | |
| GO:0043303 | Mast cell degranulation | 2 | 0.04 | |
| GO:0009620 | Response to fungus | 2 | 0.04 | |
| GO:0002448 | Mast cell mediated immunity | 2 | 0.04 | |
| GO:0009410 | Response to xenobiotic stimulus | 2 | 0.04 | |
| GO:0002279 | Mast cell activation involved in immune response | 2 | 0.05 |
GO: gene ontology, DEGs: differentially expressed genes.
Figure 5Proposed model for physiological parameters and hepatic transcriptomes related with high methane emission in Japanese Black cattle. The cattle with high methane emission seems to actively utilize the amino acid to replenish for the loss of energy used in methane production, resulting in a decrease in blood amino acid levels and an increase in blood insulin concentration with no changes of growth and productivity.